Public research footprint of The First Affiliated Hospital of Xiamen University. ( Site 2239), compiled from the ClinicalTrials.gov public registry.
Non-Small Cell Lung Cancer (NSCLC) · Relapsed/Refractory Follicular Lymphoma · HR Low-Positive/HER2-Negative Breast Neoplasms · Acute Respiratory Distress Syndrome (ARDS)
Enter your work email to view the full list.
Verify and correct how your facility appears in public registry records — free.
Verify this profile →Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.